The MiP Consortium is involved in a wide range of research activities in Africa, Asia and Latin America.
The objective of this group of projects is to identify at least two antimalarial drug combinations that are safe, effective and practical to use for the treatment of uncomplicated malaria in pregnancy in Africa, Asia and Latin America.
The objectives of this group of projects are to identify at least one safe and effective alternative to sulphadoxine-pyrimethamine (SP) for intermittent preventative treatment in pregnancy (IPTp) in Africa and to identify new strategies to replace IPTp for areas with reduced/low transmission or high SP resistance.
Prevention Asia and Latin America
The objective of this group of projects is to define the malaria burden and to determine the optimal strategy for the control of malaria in pregnancy in areas in Asia and Latin America with low or moderate malaria transmission where P falciparum and P vivax malaria coexist.
Public Health Impact
This theme consists of a series of multi disciplinary studies involving anthropology, economics and implementation research to examine what currently determines women's access to and use of care packages associated with malaria in pregnancy in differing contexts so that policy changes and other enablers can be employed to improve access within the context of antenatal care programmes.
Cross Cutting Activities
The projects that fall under the four research themes are supported by these additional projects, studies and trials which provide scientific validation and benefit across more than one project, the so-called cross cutting activities, of which there are five.